Citalopram Hydrobromide
- Product NDC
- 0615-7832
- 11-digit product format
- 006157832
- Labeler code
- 0615
- Product ID
- 0615-7832_7353a8af-3bcd-4ecb-9b66-22521aa6a29d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Citalopram Hydrobromide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NCS HealthCare of KY, Inc dba Vangard Labs
- Application
- ANDA078216
- Marketing category
- ANDA
- Marketing start
- 2007-10-18
- Marketing end
- 0000-00-00
- Substance
- CITALOPRAM HYDROBROMIDE
- Active strength
- 40 mg/1
- Pharmacologic classes
- Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 0615-7832-05 | 2021-04-09 | C162847 | 48780-1 | 9d75b9d0-be24-f424-e053-dadaa90a57ce | d2e70b74-85ef-416f-8901-9348e13f2118 |
| 0615-7832-30 | 2021-04-09 | C162847 | 48780-1 | 9d75b9d0-be24-f424-e053-dadaa90a57ce | d2e70b74-85ef-416f-8901-9348e13f2118 |
| 0615-7832-31 | 2021-04-09 | C162847 | 48780-1 | 9d75b9d0-be24-f424-e053-dadaa90a57ce | d2e70b74-85ef-416f-8901-9348e13f2118 |
| 0615-7832-39 | 2021-04-09 | C162847 | 48780-1 | 9d75b9d0-be24-f424-e053-dadaa90a57ce | d2e70b74-85ef-416f-8901-9348e13f2118 |
| 0615-7832-05 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-be24-f424-e053-dadaa90a57ce | d2e70b74-85ef-416f-8901-9348e13f2118 |
| 0615-7832-30 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-be24-f424-e053-dadaa90a57ce | d2e70b74-85ef-416f-8901-9348e13f2118 |
| 0615-7832-31 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-be24-f424-e053-dadaa90a57ce | d2e70b74-85ef-416f-8901-9348e13f2118 |
| 0615-7832-39 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-be24-f424-e053-dadaa90a57ce | d2e70b74-85ef-416f-8901-9348e13f2118 |